COVID-19 vaccine efficacy against variants

Note: *In US trials. Average of 66% efficacy with South Africa and Latin America trials included.

Source: UW Medicine; Reuters; Lancet; Lancet Preprint; Biorxiv; Moderna; Nature; New England Journal of Medicine; Imperial College London; CDC;CoV-lineages.org.